For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220823:nRSW9639Wa&default-theme=true
RNS Number : 9639W Dr. Martens PLC 23 August 2022
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial
Responsibility
Dr. Martens plc (the "Company") announces that it has been notified of the
following transactions in the Company's Ordinary shares undertaken on behalf
of directors / persons discharging managerial responsibility ('PDMRs') under
the Company's Global Bonus Scheme.
Under the terms of the Company's Remuneration Policy, one third of any annual
bonus payable to the Executive Directors each year, net of tax and national
insurance, will be used to purchase shares which the Executive Directors are
required to hold for two years.
The relevant notifications set out below are provided in accordance with the
requirements of Article 19 of the Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Kenny Wilson
2 Reason for the notification
a) Position/status PDMR (Chief Executive Officer)
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Dr. Martens plc
b) LEI 213800QPT8YM6NQZPH28
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of GBP 0.01
Identification code
ISIN: GB00BL6NGV24
b) Nature of the transaction Purchase of Ordinary shares under the Global Bonus Scheme
c) Price(s) and volume(s) Price(s) Volume(s)
£2.75115 55,867 shares
d) Aggregated information
- Aggregated volume
55,867 shares
£2.75115
- Price
e) Date of the transaction 2022-07-25
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information
- Aggregated volume
- Price
55,867 shares
£2.75115
e)
Date of the transaction
2022-07-25
f)
Place of the transaction
London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jon Mortimore
2 Reason for the notification
a) Position/status PDMR (Chief Financial Officer)
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Dr. Martens plc
b) LEI 213800QPT8YM6NQZPH28
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of GBP 0.01
Identification code
ISIN: GB00BL6NGV24
b) Nature of the transaction Purchase of Ordinary shares under the Global Bonus Scheme
c) Price(s) and volume(s) Price(s) Volume(s)
£2.75115 26,936 shares
d) Aggregated information
- Aggregated volume
26,936 shares
£2.75115
- Price
e) Date of the transaction 2022-07-25
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information
- Aggregated volume
- Price
26,936 shares
£2.75115
e)
Date of the transaction
2022-07-25
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUOOORUWUWUAR